Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Advanced Non Small Cell Lung Cancer × toripalimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Nasopharyngeal Carcinoma 19 Carcinoma, Non-Small-Cell Lung 18 Esophageal Squamous Cell Carcinoma 15 Breast Neoplasms 14 Triple Negative Breast Neoplasms 13 Squamous Cell Carcinoma of Head and Neck 11 Carcinoma, Hepatocellular 11 Stomach Neoplasms 8 Small Cell Lung Carcinoma 8 Uterine Cervical Neoplasms 6 Recurrence 6 Head and Neck Neoplasms 6 Colorectal Neoplasms 5 Carcinoma, Transitional Cell 5 Urinary Bladder Neoplasms 4 Sarcoma 4 Rectal Neoplasms 4 Neoplasm Metastasis 4 Melanoma 4 Laryngeal Neoplasms 4 Hypopharyngeal Neoplasms 4 Carcinoma, Renal Cell 4 Liver Neoplasms 3 Pathologic Complete Response 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Oropharyngeal Neoplasms 2 Nasopharyngeal Neoplasms 2 NSCLC 2 Muscle Invasive Bladder Cancer (MIBC) 2

Interventions

toripalimab 1 sintilimab 1 pemigatinib 1 Vinorelbine 1 Platinum Compounds 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04144608 2024-08-09

TOGATHER

Hunan Province Tumor Hospital

Phase 2 Completed

Advanced Non Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡